MAGAININ PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-11-07
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: MAGAININ PHARMACEUTICALS INC, 10-Q, 2000-11-07
Next: NAVISTAR FINANCIAL RETAIL RECEIVABLES CORPORATION, 8-K, 2000-11-07



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM MAGAININ
PHARMACEUTICAL INC.'S BALANCE SHEET AS OF SEPTEMBER 30, 2000 AND THE RELATED
STATEMENT OF INCOME FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                             666
<SECURITIES>                                    21,012
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                21,951
<PP&E>                                           4,563
<DEPRECIATION>                                   3,309
<TOTAL-ASSETS>                                  23,376
<CURRENT-LIABILITIES>                            5,624
<BONDS>                                              0
                              523
                                          0
<COMMON>                                            65
<OTHER-SE>                                      14,906
<TOTAL-LIABILITY-AND-EQUITY>                    23,376
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 8,864
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 489
<INCOME-PRETAX>                                (8,789)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (8,812)
<EPS-BASIC>                                      (.31)
<EPS-DILUTED>                                    (.31)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission